Replies to post #325499 on Anavex Life Sciences Corp (AVXL)

[kevindenver]

You just condensed about 10 years of research into 6 small paragraphs, impressive. Thank you.

[Kmadd]

You had once written that Aricept may take up space on the Sigma1 molecule. I'm wonder if you still think that, as well how long do you think patients would have to stop taking it in order for blarcasamine to be more effective?
Also Im wondering if this may effect some of these other trials going on with Sava, etc.

[nidan7500]

Well done Falconer66a. Thanks for your continuing-ongoing assessments here. We periodically see new PR-treatment claims, sponsored by MM and the WS crew, that gets tiring. It looks to me like WS-MM and assorted new CNS shiny things are untested to a level we need to see. They take the $$ and run a few weeks later.

By not going the IPO path AVXL presents ongoing gut checks. This WS system seems to encourage false or incomplete claims. The latest BIIB re-do's present good examples of this. BUT, it looks like some insurance co.s and VA have said ..."Stop the train." We'll see how that works. Would like to think that a , "management by example" execution process is out there waiting for good candidates.

[powerwalker]

Thanks, falconer. Great work.

[xodcode]

Once again, quality information.

Much appreciated falconer66a1